Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124926452 | 12492645 | 2 | F | 20160228 | 20160727 | 20160623 | 20160805 | EXP | US-AMGEN-USASL2016080393 | AMGEN | 91.00 | YR | E | F | Y | 58.40000 | KG | 20160805 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124926452 | 12492645 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG, Q6MO | 1057269 | 125320 | 60 | MG | SOLUTION FOR INJECTION | ||||||
| 124926452 | 12492645 | 2 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 2000 UNIT, QD | 0 | QD | ||||||||||
| 124926452 | 12492645 | 3 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 20 MG (ONE AND A HALF), QD | 0 | 20 | MG | QD | ||||||||
| 124926452 | 12492645 | 4 | C | METOPROLOL. | METOPROLOL | 1 | 25 MG, BID | 0 | 25 | MG | BID | ||||||||
| 124926452 | 12492645 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 2.5 MG, QD | 0 | 2.5 | MG | QD | ||||||||
| 124926452 | 12492645 | 6 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 124926452 | 12492645 | 7 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | 1 TABLET OCCASIONALLY | 0 | |||||||||||
| 124926452 | 12492645 | 8 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 70 MG, QWK | 0 | 70 | MG | /wk | ||||||||
| 124926452 | 12492645 | 9 | C | IRON | IRON | 1 | 27 MG, QD | 0 | 27 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124926452 | 12492645 | 1 | Osteoporosis |
| 124926452 | 12492645 | 5 | Blood pressure systolic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124926452 | 12492645 | OT |
| 124926452 | 12492645 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124926452 | 12492645 | Adverse event | |
| 124926452 | 12492645 | Agitation | |
| 124926452 | 12492645 | Anal incontinence | |
| 124926452 | 12492645 | Anxiety | |
| 124926452 | 12492645 | Aortic stenosis | |
| 124926452 | 12492645 | Arthralgia | |
| 124926452 | 12492645 | Asthenia | |
| 124926452 | 12492645 | Cardiac failure | |
| 124926452 | 12492645 | Constipation | |
| 124926452 | 12492645 | Death | |
| 124926452 | 12492645 | Decreased appetite | |
| 124926452 | 12492645 | Essential hypertension | |
| 124926452 | 12492645 | Fatigue | |
| 124926452 | 12492645 | Hip fracture | |
| 124926452 | 12492645 | Hypokalaemia | |
| 124926452 | 12492645 | Nausea | |
| 124926452 | 12492645 | Pain | |
| 124926452 | 12492645 | Pyrexia | |
| 124926452 | 12492645 | Somnolence | |
| 124926452 | 12492645 | Vascular dementia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124926452 | 12492645 | 1 | 20150818 | 0 |